Predictors of Conversion to Dementia in Patients With Mild Cognitive Impairment: The Role of Low Body Temperature.

Clock drawing Dementia Family history Low body temperature Mild cognitive impairment Risk factors

Journal

Journal of clinical medicine research
ISSN: 1918-3003
Titre abrégé: J Clin Med Res
Pays: Canada
ID NLM: 101538301

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 04 02 2023
accepted: 30 03 2023
medline: 16 5 2023
pubmed: 16 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

Subjects with mild cognitive impairment (MCI) can progress to dementia. Studies have shown that neuropsychological tests, biological or radiological markers individually or in combination have helped to determine the risk of conversion from MCI to dementia. These techniques are complex and expensive, and clinical risk factors were not considered in these studies. This study examined demographic, lifestyle and clinical factors including low body temperature that may play a role in the conversion of MCI to dementia in elderly patients. In this retrospective study, a chart review was conducted on patients aged 61 to 103 years who were seen at the University of Alberta Hospital. Information on onset of MCI and demographic, social, and lifestyle factors, family history of dementia and clinical factors, and current medications at baseline was collected from patient charts on an electronic database. The conversion from MCI to dementia within 5.5 years was also determined. Logistic regression analysis was conducted to identify the baseline factors associated with conversion from MCI to dementia. The prevalence of MCI at baseline was 25.6% (335/1,330). During the 5.5 years follow-up period, 43% (143/335) of the subjects converted to dementia from MCI. The factors that were significantly associated with conversion from MCI to dementia were family history of dementia (odds ratio (OR): 2.78, 95% confidence interval (CI): 1.56 - 4.95, P = 0.001), Montreal cognitive assessment (MoCA) score (OR: 0.91, 95% CI: 0.85 - 0.97, P = 0.01), and low body temperature (below 36 °C) (OR: 10.01, 95% CI: 3.59 - 27.88, P < 0.001). In addition to family history of dementia and MoCA, low body temperature was shown to be associated with the conversion from MCI to dementia. This study would help clinicians to identify patients with MCI who are at highest risk of conversion to dementia.

Sections du résumé

Background UNASSIGNED
Subjects with mild cognitive impairment (MCI) can progress to dementia. Studies have shown that neuropsychological tests, biological or radiological markers individually or in combination have helped to determine the risk of conversion from MCI to dementia. These techniques are complex and expensive, and clinical risk factors were not considered in these studies. This study examined demographic, lifestyle and clinical factors including low body temperature that may play a role in the conversion of MCI to dementia in elderly patients.
Methods UNASSIGNED
In this retrospective study, a chart review was conducted on patients aged 61 to 103 years who were seen at the University of Alberta Hospital. Information on onset of MCI and demographic, social, and lifestyle factors, family history of dementia and clinical factors, and current medications at baseline was collected from patient charts on an electronic database. The conversion from MCI to dementia within 5.5 years was also determined. Logistic regression analysis was conducted to identify the baseline factors associated with conversion from MCI to dementia.
Results UNASSIGNED
The prevalence of MCI at baseline was 25.6% (335/1,330). During the 5.5 years follow-up period, 43% (143/335) of the subjects converted to dementia from MCI. The factors that were significantly associated with conversion from MCI to dementia were family history of dementia (odds ratio (OR): 2.78, 95% confidence interval (CI): 1.56 - 4.95, P = 0.001), Montreal cognitive assessment (MoCA) score (OR: 0.91, 95% CI: 0.85 - 0.97, P = 0.01), and low body temperature (below 36 °C) (OR: 10.01, 95% CI: 3.59 - 27.88, P < 0.001).
Conclusion UNASSIGNED
In addition to family history of dementia and MoCA, low body temperature was shown to be associated with the conversion from MCI to dementia. This study would help clinicians to identify patients with MCI who are at highest risk of conversion to dementia.

Identifiants

pubmed: 37187716
doi: 10.14740/jocmr4883
pmc: PMC10181356
doi:

Types de publication

Journal Article

Langues

eng

Pagination

216-224

Informations de copyright

Copyright 2023, Alagiakrishnan et al.

Déclaration de conflit d'intérêts

The authors report no conflict of interest in this work.

Références

Arch Gen Psychiatry. 2003 Feb;60(2):190-7
pubmed: 12578437
ACS Chem Neurosci. 2019 Mar 20;10(3):1118-1120
pubmed: 30657675
Int J Cardiol. 2017 Feb 1;228:558-562
pubmed: 27875734
Dement Geriatr Cogn Disord. 2009;27(3):201-13
pubmed: 19225234
Curr Alzheimer Res. 2010 Dec;7(8):717-25
pubmed: 20678067
Ageing Res Rev. 2002 Sep;1(4):721-78
pubmed: 12208240
Temperature (Austin). 2015 Oct 19;2(4):491-8
pubmed: 27227069
Sleep. 2020 Apr 15;43(4):
pubmed: 31702011
PLoS One. 2019 May 22;14(5):e0216362
pubmed: 31116745
Front Aging Neurosci. 2021 Feb 12;13:585904
pubmed: 33643019
BMC Res Notes. 2013 May 10;6:194
pubmed: 23663659
Prev Med Rep. 2020 Oct 02;20:101221
pubmed: 33088678
JAMA. 1997 Oct 22-29;278(16):1349-56
pubmed: 9343467
J Neural Transm (Vienna). 2012 Oct;119(10):1185-94
pubmed: 22828713
J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):343-4
pubmed: 14742628
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Anesthesiology. 1994 Apr;80(4):780-8
pubmed: 8024131
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2012;19(1-2):248-63
pubmed: 22313174
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
Neurology. 2007 Mar 13;68(11):828-36
pubmed: 17353470
Br Med J (Clin Res Ed). 1986 Aug 16;293(6544):416-8
pubmed: 3091139
Neurobiol Aging. 2016 Jul;43:47-57
pubmed: 27255814
J Med Eng Technol. 2006 Jul-Aug;30(4):242-51
pubmed: 16864236
J Alzheimers Dis. 2012;31(3):659-68
pubmed: 22669011
Sports Med. 2002;32(14):879-85
pubmed: 12427049
Practitioner. 1995 Jan;239(1546):22-6
pubmed: 7708605
Med Hypotheses. 2000 Nov;55(5):440-4
pubmed: 11058425
J Gerontol A Biol Sci Med Sci. 2011 May;66(5):487-92
pubmed: 21324956
Drugs Aging. 2015 May;32(5):337-48
pubmed: 25948549
Ergonomics. 2012;55(7):792-8
pubmed: 22506538
Gerontologist. 1970 Spring;10(1):20-30
pubmed: 5420677
J Alzheimers Dis. 2013;34(3):769-80
pubmed: 23271318
Neurobiol Dis. 2022 Sep;171:105748
pubmed: 35550158
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Dement Geriatr Cogn Dis Extra. 2017 Feb 2;7(1):15-29
pubmed: 28413413
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Gerontology. 2012;58(4):289-95
pubmed: 22085834
Neurology. 2018 Aug 21;91(8):e759-e768
pubmed: 30045960
Environ Pollut. 2021 Sep 15;285:117474
pubmed: 34087635
Brain Sci. 2022 Jan 12;12(1):
pubmed: 35053838
Curr Alzheimer Res. 2006 Apr;3(2):161-70
pubmed: 16611017
J Am Geriatr Soc. 1991 May;39(5):532
pubmed: 2022805
J Sleep Res. 2020 Oct;29(5):e12939
pubmed: 31713306
J Alzheimers Dis. 2013;36(3):421-31
pubmed: 23635408
J Clin Diagn Res. 2016 Mar;10(3):CC11-5
pubmed: 27134865
J Neurosci. 2004 Mar 10;24(10):2401-11
pubmed: 15014115
Neurology. 2004 Nov 23;63(10):1898-901
pubmed: 15557508
Dement Geriatr Cogn Disord. 2011;31(6):431-4
pubmed: 21757908
Hum Mol Genet. 1994 Apr;3(4):569-74
pubmed: 8069300
J Alzheimers Dis. 2010;20(3):881-91
pubmed: 20413876
Neurology. 1996 Mar;46(3):641-50
pubmed: 8618660
Anesthesiology. 2012 Apr;116(4):779-87
pubmed: 22343471
J Alzheimers Dis. 2014;38(3):481-95
pubmed: 24002185

Auteurs

Kannayiram Alagiakrishnan (K)

Division of Geriatric Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Prabhpaul Dhami (P)

Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Ambikaipakan Senthilselvan (A)

School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Classifications MeSH